TY - JOUR
T1 - Conditioning with sevoflurane in liver transplantation
T2 - Results of a multicenter randomized controlled trial
AU - Beck-Schimmer, Beatrice
AU - Bonvini, John M.
AU - Schadde, Erik
AU - Dutkowski, Philipp
AU - Oberkofler, Christian E.
AU - Lesurtel, Mickael
AU - DeOliveira, Michelle L.
AU - Figueira, Estela R R
AU - Filho, Joel A Rocha
AU - Auler, Jose Otavio Costa
AU - D'Albuquerque, Luiz A C
AU - Reyntjens, Koen
AU - Wouters, Patrick
AU - Rogiers, Xavier
AU - Debaerdemaeker, Luc
AU - Ganter, Michael T.
AU - Weber, Achim
AU - Puhan, Milo A.
AU - Clavien, Pierre Alain
AU - Breitenstein, Stefan
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Background. During times of organ scarcity and extended use of liver grafts, protective strategies in transplantation are gaining importance. We demonstrated in the past that volatile anesthetics such as sevoflurane attenuate ischemia-reperfusion injury during liver resection. In this randomized study, we examined if volatile anesthetics have an effect on acute graft injury and clinical outcomes after liver transplantation. Methods. Cadaveric liver transplant recipients were enrolled from January 2009 to September 2012 at 3 University Centers (Zurich/Sao Paulo/Ghent). Recipients were randomly assigned to propofol (control group) or sevoflurane anesthesia. Postoperative peak of aspartate transaminase was defined as primary endpoint, secondary endpoints were early allograft dysfunction, in-hospital complications, intensive care unit, and hospital stay. Results. Ninetyeight recipients were randomized to propofol (n = 48) or sevoflurane (n = 50). Median peak aspartate transaminase after transplantation was 925 (interquartile range, 512-3274) in the propofol and 1097 (interquartile range, 540-2633) in the sevoflurane group. In the propofol arm, 11 patients (23%) experienced early allograft dysfunction, 7 (14%) in the sevoflurane one (odds ratio, 0.64 (0.20 to 2.02, P = 0.45). There were 4 mortalities (8.3%) in the propofol and 2 (4.0%) in the sevoflurane group. Overall and major complication rates were not different. An effect on clinical outcomes was observed favoring the sevoflurane group (less severe complications), but without significance. Conclusions. This first multicenter trial comparing propofol with sevoflurane anesthesia in liver transplantation shows no difference in biochemical markers of acute organ injury and clinical outcomes between the 2 regimens. Sevoflurane has no significant added beneficial effect on ischemia-reperfusion injury compared to propofol.
AB - Background. During times of organ scarcity and extended use of liver grafts, protective strategies in transplantation are gaining importance. We demonstrated in the past that volatile anesthetics such as sevoflurane attenuate ischemia-reperfusion injury during liver resection. In this randomized study, we examined if volatile anesthetics have an effect on acute graft injury and clinical outcomes after liver transplantation. Methods. Cadaveric liver transplant recipients were enrolled from January 2009 to September 2012 at 3 University Centers (Zurich/Sao Paulo/Ghent). Recipients were randomly assigned to propofol (control group) or sevoflurane anesthesia. Postoperative peak of aspartate transaminase was defined as primary endpoint, secondary endpoints were early allograft dysfunction, in-hospital complications, intensive care unit, and hospital stay. Results. Ninetyeight recipients were randomized to propofol (n = 48) or sevoflurane (n = 50). Median peak aspartate transaminase after transplantation was 925 (interquartile range, 512-3274) in the propofol and 1097 (interquartile range, 540-2633) in the sevoflurane group. In the propofol arm, 11 patients (23%) experienced early allograft dysfunction, 7 (14%) in the sevoflurane one (odds ratio, 0.64 (0.20 to 2.02, P = 0.45). There were 4 mortalities (8.3%) in the propofol and 2 (4.0%) in the sevoflurane group. Overall and major complication rates were not different. An effect on clinical outcomes was observed favoring the sevoflurane group (less severe complications), but without significance. Conclusions. This first multicenter trial comparing propofol with sevoflurane anesthesia in liver transplantation shows no difference in biochemical markers of acute organ injury and clinical outcomes between the 2 regimens. Sevoflurane has no significant added beneficial effect on ischemia-reperfusion injury compared to propofol.
UR - http://www.scopus.com/inward/record.url?scp=84942416899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942416899&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000000644
DO - 10.1097/TP.0000000000000644
M3 - Article
C2 - 25769076
AN - SCOPUS:84942416899
VL - 99
SP - 1606
EP - 1612
JO - Transplantation
JF - Transplantation
SN - 0041-1337
IS - 8
ER -